Biotechnology Stocks
| # | Ultimi 7 Giorni | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3852 |  ANIX Anixa Biosciences, Inc. - Common Stock | 3.55 USD | -4.31% | +9.23% | -4.31% | +17.55% | 120.78 M USD | ||
| 3854 |  VANI Vivani Medical, Inc. - Common Stock | 1.36 USD | -1.45% | -1.45% | +4.62% | +9.68% | 122.68 M USD | ||
| 3855 |  GUTS Fractyl Health, Inc. - Common Stock | 0.76 USD | -2.56% | +11.76% | -3.80% | -24.00% | 120.98 M USD | ||
| 3856 |  GNLX Genelux Corporation - Common Stock | 2.58 USD | -5.15% | -3.73% | -12.84% | -31.56% | 116.73 M USD | ||
| 3858 |  RANI Rani Therapeutics Holdings, Inc. - Class A Common Stock | 0.87 USD | -1.14% | +7.41% | +6.10% | +40.32% | 121.27 M USD | ||
| 3864 |  INO Inovio Pharmaceuticals, Inc. - Common Stock | 1.18 USD | 0.00% | +5.36% | +20.41% | -39.49% | 122.01 M USD | ||
| 3867 |  NTHI NeOnc Technologies Holdings, Inc. - Common Stock | 4.77 USD | +1.92% | +20.15% | +39.07% | -45.61% | 123.72 M USD | ||
| 3870 |  NAUT Nautilus Biotechnology, Inc. - Common Stock | 0.90 USD | -5.26% | +1.12% | -47.37% | +28.57% | 114.53 M USD | ||
| 3877 |  ENGN enGene Therapeutics Inc. - Common Stock | 1.77 USD | -0.56% | +3.51% | -4.32% | -78.93% | 118.57 M USD | ||
| 3890 |  COYA Coya Therapeutics, Inc. - Common Stock | 4.80 USD | -1.44% | +2.78% | +10.85% | -32.87% | 112.60 M USD | ||
| 3896 |  SEER Seer, Inc. - Class A Common Stock | 2.03 USD | 0.00% | 0.00% | +2.53% | -2.40% | 112.41 M USD | ||
| 3911 |  ONCY Oncolytics Biotech Inc. - Common Stock | 0.81 USD | -3.57% | -2.41% | +1.25% | -19.80% | 103.28 M USD | ||
| 3947 |  BMEA Biomea Fusion, Inc. - Common Stock | 1.68 USD | +22.63% | +25.37% | +33.33% | -9.19% | 121.77 M USD | ||
| 3950 |  KLRS Kalaris Therapeutics, Inc. - Common Stock | 4.06 USD | -2.17% | -1.46% | +8.27% | -60.31% | 96.65 M USD | ||
| 3955 |  ATRA Atara Biotherapeutics, Inc. - Common Stock | 9.57 USD | -1.34% | +21.91% | +18.73% | -35.12% | 96.06 M USD | ||
| 3962 |  FBIO Fortress Biotech, Inc. - Common Stock | 2.88 USD | +0.35% | +1.41% | -14.29% | +26.32% | 96.05 M USD | ||
| 3967 |  CGTX Cognition Therapeutics, Inc. - Common Stock | 0.98 USD | -2.00% | -2.97% | +4.26% | -68.99% | 93.19 M USD | ||
| 3969 |  ACRV Acrivon Therapeutics, Inc. - Common Stock | 2.12 USD | -4.07% | +4.95% | +30.86% | +58.21% | 90.85 M USD | ||
| 3979 |  PYPD PolyPid Ltd. - Ordinary Shares | 5.08 USD | -0.39% | +7.17% | +28.61% | +47.25% | 92.48 M USD | ||
| 3989 |  ALDX Aldeyra Therapeutics, Inc. - Common Stock | 1.50 USD | -1.32% | -3.23% | -1.96% | -74.23% | 90.49 M USD |
Notizie Biotechnology Stocks
Deutsche Bank declassa argenx a Hold per valutazione
Perché il titolo di Monte Rosa Therapeutics scende oggi?
Il titolo di Biomea Fusion balza dopo il completamento dell’arruolamento nel trial sul diabete
Il titolo di Monte Rosa cala con l’avvio dello studio di fase 2 sul cancro alla prostata
H.C. Wainwright conferma il rating su Biomea Fusion dopo l’arruolamento nel trial
Il titolo azionario di Crinetics Pharmaceuticals raggiunge il massimo storico a 84,8 USD
La FDA estende la revisione di deramiocel di Capricor al 22 novembre
Gainers Biotechnology Stocks
 SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
 RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
 ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
 NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
 OABIW OmniAb, Inc. - Warrant | 0.2339 | +37.59% |
 LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
 CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
Losers Biotechnology Stocks
 HUMAW Humacyte, Inc. - Warrant | 0.0050 | -44.44% |
 CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
 RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
 ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
 APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
 BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
 YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |
 SNTI Senti Biosciences, Inc. - Common Stock | 0.35 | -10.26% |